Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FRC
First Republic Bank
FRC
|
+$734M |
| 2 |
Boeing
BA
|
+$493M |
| 3 |
Pfizer
PFE
|
+$478M |
| 4 |
UnitedHealth
UNH
|
+$440M |
| 5 |
Honeywell
HON
|
+$364M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.05B |
| 2 |
Advanced Micro Devices
AMD
|
+$447M |
| 3 |
TSMC
TSM
|
+$441M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 5 |
ExxonMobil
XOM
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.34% |
| 2 | Technology | 16.84% |
| 3 | Consumer Discretionary | 12.66% |
| 4 | Industrials | 10.11% |
| 5 | Consumer Staples | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BRDG
2526
DELISTED
Bridge Investment Group
BRDG
| $928K | ﹤0.01% |
81,900
-60,800
| -43% | -$821K |
|
2527
TETRA Technologies
TTI
$1.15B
| $928K | ﹤0.01% |
350,276
+14,600
| +4% | +$50.8K |
|
2528
Invesco Taxable Municipal Bond ETF
BAB
$1.01B
| $927K | ﹤0.01% |
34,500
+2,753
| +9% | +$73.3K |
|
|
FFAI
2529
Faraday Future Intelligent Electric
FFAI
$12.6M
| $926K | ﹤0.01% |
2
-1
| -33% | -$822K |
|
|
HYPD
2530
Hyperion DeFi Inc
HYPD
$40.3M
| $925K | ﹤0.01% |
3,275
-331
| -9% | -$70K |
|
2531
Passage Bio
PASG
$14.4M
| $924K | ﹤0.01% |
48,245
-11,313
| -19% | -$307K |
|
|
VRAY
2532
DELISTED
ViewRay, Inc.
VRAY
| $924K | ﹤0.01% |
+267,100
| New | +$1.13M |
|
2533
Bakkt Inc
BKKT
$329M
| $921K | ﹤0.01% |
21,408
+11,340
| +113% | +$441K |
|
2534
loanDepot
LDI
$586M
| $917K | ﹤0.01% |
569,700
-245,600
| -30% | -$514K |
|
2535
SPDR Gold MiniShares Trust
GLDM
$27.5B
| $915K | ﹤0.01% |
+23,400
| New | +$879K |
|
2536
FB Financial Corp
FBK
$3.05B
| $914K | ﹤0.01% |
29,400
+1,600
| +6% | +$57.2K |
|
2537
Taylor Devices
TAYD
$169M
| $913K | ﹤0.01% |
45,562
+12,500
| +38% | +$199K |
|
|
CTLP
2538
DELISTED
Cantaloupe
CTLP
| $912K | ﹤0.01% |
160,000
-263,635
| -62% | -$1.4M |
|
2539
National Bankshares
NKSH
$262M
| $911K | ﹤0.01% |
28,970
-6,000
| -17% | -$238K |
|
2540
Viridian Therapeutics
VRDN
$2.13B
| $911K | ﹤0.01% |
+35,800
| New | +$1.15M |
|
2541
XPeng
XPEV
$11.8B
| $910K | ﹤0.01% |
81,929
-7,236,771
| -99% | -$69.9M |
|
|
ARIS
2542
DELISTED
Aris Water Solutions
ARIS
| $906K | ﹤0.01% |
116,300
-300
| -0.3% | -$3.87K |
|
|
OGI
2543
Organigram Holdings
OGI
$136M
| $906K | ﹤0.01% |
353,875
+75,584
| +27% | +$240K |
|
2544
Trinity Industries
TRN
$2.5B
| $906K | ﹤0.01% |
37,200
-56,600
| -60% | -$1.5M |
|
|
MRNS
2545
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $906K | ﹤0.01% |
131,300
-31,400
| -19% | -$197K |
|
2546
Pure Cycle
PCYO
$258M
| $902K | ﹤0.01% |
95,400
+73,500
| +336% | +$677K |
|
2547
Root
ROOT
$903M
| $901K | ﹤0.01% |
199,688
-26,352
| -12% | -$134K |
|
|
DFSD
2548
Dimensional Short-Duration Fixed Income ETF
DFSD
$7.13B
| $896K | ﹤0.01% |
19,200
+3,198
| +20% | +$149K |
|
2549
Archer Aviation
ACHR
$3.69B
| $895K | ﹤0.01% |
312,900
+206,000
| +193% | +$556K |
|
2550
Olema Pharmaceuticals
OLMA
$985M
| $892K | ﹤0.01% |
257,200
-9,000
| -3% | -$36.7K |
|
Similar funds
Renaissance Technologies's Q1 2023 Portfolio in Review
As of Q1 2023, Renaissance Technologies held 4,600 positions worth $75.4B, up 3.1% from $73.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2023 filing shows 524 new, 1,665 increased, 1,689 reduced and 668 closed positions. Its largest new stake was Honeywell: 1,937,917 shares worth $349M. The largest sale was Apple, an estimated $1.05B.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Technology and Consumer Discretionary.
- Renaissance Technologies's largest Q1 2023 buy was Honeywell: 1,937,917 shares worth $349M.
- Renaissance Technologies added most to First Republic Bank in Q1 2023, an estimated $734M increase.
- Renaissance Technologies's biggest Q1 2023 reduction was Apple, cutting an estimated $1.05B.
- Renaissance Technologies fully exited Advanced Micro Devices in Q1 2023, selling an estimated $447M.
- Renaissance Technologies's ten largest holdings make up 11% of its $75.4B portfolio in Q1 2023.
- Renaissance Technologies opened 524 new positions and closed 668 in Q1 2023.
- Renaissance Technologies's portfolio value rose 3.1% quarter-over-quarter to $75.4B.
Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.